Evidence map›Paper›PMID 28601643›Full record

ArticleNeoplasia (New York, N.Y.)2017

Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.

Yuliya Klymenko, Jeffrey Johnson, Brandi Bos, Rachel Lombard, Leigh Campbell, Elizabeth Loughran, M Sharon Stack

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Collective metastasis: coordinating the multicellular voyage.Clinical & experimental metastasis · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yuliya KlymenkoDept. of Biological Sciences, University of Notre Dame, South Bend, IN, 46617; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617.
Jeffrey JohnsonHarper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617.
Brandi BosDept. of Biological Sciences, University of Notre Dame, South Bend, IN, 46617; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617.
Rachel LombardHarper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617.
Leigh CampbellHarper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617.
Elizabeth LoughranHarper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617; Dept. of Chemistry and Biochemistry, University of Notre Dame, South Bend, IN, 46617.
M Sharon StackDept. of Biological Sciences, University of Notre Dame, South Bend, IN, 46617; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, 46617; Dept. of Chemistry and Biochemistry, University of Notre Dame, South Bend, IN, 46617. Electronic address: sstack@nd.edu.
University of Notre Dame · USCancer Research Institute · US

Funding

Receptor Cross-Talk in Early Metastatic DisseminationR01CA109545 · NCI · UNIVERSITY OF NOTRE DAME · PI STACK, MARY SHARON · 2006 to 2022
$4.3M
REGULATION OF OVARIAN CARCINOMA PROTEINASESR01CA086984 · NCI · UNIVERSITY OF NOTRE DAME · PI STACK, MARY SHARON · 2000 to 2014
$3.8M
NCI NIH HHS R01 CA086984NCI NIH HHS R01 CA109545
6 · The paper itself

Abstract

Epithelial ovarian carcinoma spreads via shedding of cells and multicellular aggregates (MCAs) from the primary tumor into peritoneal cavity, with subsequent intraperitoneal tumor cell:mesothelial cell adhesion as a key early event in metastatic seeding. Evaluation of human tumor extracts and tissues confirms that well-differentiated ovarian tumors express abundant E-cadherin (Ecad), whereas advanced lesions exhibit upregulated N-cadherin (Ncad). Two expression patterns are observed: "mixed cadherin," in which distinct cells within the same tumor express either E- or Ncad, and "hybrid cadherin," wherein single tumor cell(s) simultaneously expresses both cadherins. We demonstrate striking cadherin-dependent differences in cell-cell interactions, MCA formation, and aggregate ultrastructure. Mesenchymal-type Ncad+ cells formed stable, highly cohesive solid spheroids, whereas Ecad+ epithelial-type cells generated loosely adhesive cell clusters covered by uniform microvilli. Generation of "mixed cadherin" MCAs using fluorescently tagged cell populations revealed preferential sorting into cadherin-dependent clusters, whereas mixing of cell lines with common cadherin profiles generated homogeneous aggregates. Recapitulation of the "hybrid cadherin" Ecad+/Ncad+ phenotype, via insertion of the CDH2 gene into Ecad+ cells, resulted in the ability to form heterogeneous clusters with Ncad+ cells, significantly enhanced adhesion to organotypic mesomimetic cultures and peritoneal explants, and increased both migration and matrix invasion. Alternatively, insertion of CDH1 gene into Ncad+ cells greatly reduced cell-to-collagen, cell-to-mesothelium, and cell-to-peritoneum adhesion. Acquisition of the hybrid cadherin phenotype resulted in altered MCA surface morphology with increased surface projections and increased cell proliferation. Overall, these findings support the hypothesis that MCA cadherin composition impacts intraperitoneal cell and MCA dynamics and thereby affects ultimate metastatic success.

Indexed as

Gene ExpressionCadherinsCarcinoma, Ovarian EpithelialCell AdhesionCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionFemaleHumansNeoplasms, Glandular and EpithelialNeoplasm StagingOvarian NeoplasmsPhenotypeTissue Array AnalysisCadherins

Identifiers

PMID28601643
PMCPMC5497527
OpenAlexW2623049878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.